Dr. Miele Cosmed Group S.A. (DMG.WA)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in PLN| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | PLN m | 365 | 352 | 397 | 444 | - | 504 | 496 | - |
| Operating profit | PLN m | 30 | 19 | ||||||
| Net profit | PLN m | 29 | 12 | -2 | 22 | - | 20 | 12 | - |
| EPS reported | PLN | 0.23 | 0.15 | ||||||
| Operating cashflow per share | PLN | 0.40 | 0.39 | ||||||
| Capex per share | PLN | 0.30 | 0.31 | ||||||
| FCF per share | PLN | 0.10 | 0.08 | ||||||
| Free cash flow | PLN m | 8 | 3 | ||||||
| Net debt | PLN m | 41 | 59 | ||||||
| Book value equity | PLN m | 270 | 275 | ||||||
| Book value per share | PLN | 3.15 | 3.21 | ||||||
| Number of shares | m | 85.82 | 85.78 | ||||||
| DPS (TTM paid) | PLN | 0.15 | 0.08 |
Financial summary
Financials in PLN| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 11.26 | 10.99 | ||||||
| P/B LTM | x | 0.82 | 0.81 | ||||||
| P/S LTM | x | 0.44 | 0.45 | ||||||
| P/FCF LTM | x | 26.37 | 71.03 | ||||||
| EV/EBITDA LTM | x | 6.20 | 7.87 | ||||||
| EV/Sales LTM | x | 0.54 | 0.51 | ||||||
| Earnings Yield LTM | % | +8.88% | +9.10% | ||||||
| FCF Yield | % | +3.79% | +1.41% | ||||||
| Quality | |||||||||
| ROE | % | +7.29% | +6.04% | ||||||
| ROIC | % | +6.66% | +5.15% | ||||||
| Operating margin | % | +5.89% | +4.85% | ||||||
| Gross margin | % | +34.42% | +33.81% | ||||||
| FCF/Sales | % | +1.67% | +1.46% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -8.00% | - | ||||||
| Sales Growth YoY | % | +13.44% | - | ||||||
| Net Income Growth YoY | % | -11.38% | - | ||||||
| FCF Growth | % | -60.90% | - | ||||||
| Operating Profit Growth | % | -10.14% | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +1.93% | +3.52% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | +21.73% | 0.00% | ||||||
| FCF/Debt | x | 0.13 | 0.05 | ||||||
| Net Debt/EBITDA | x | 1.17 | 1.52 | ||||||
| EBIT/Net interest | x | 6.07 | 5.52 | ||||||
| Net debt/market cap | % | +23.91% | +26.38% | ||||||
| Net debt/Equity | x | 0.15 | 0.22 | ||||||
| Gross debt/equity | x | 0.23 | 0.23 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Dr. Miele Cosmed Group S.A., founded in 1990 and headquartered in Radom, Poland, is actively involved in the global production and distribution of a diverse array of chemical and cosmetic products. Their extensive portfolio includes personal hygiene items such as shower gels, liquid soaps, and sanitizing gels and sprays, alongside a dedicated range for children encompassing washing and care cosmetics, wet wipes, and laundry detergents. The company also manufactures household cleaning essentials, offering toilet cleaners, toilet blocks, drain openers (in granule and gel form), washing liquids, fabric softening concentrates, and specific agents for kitchen and bathroom cleaning, as well as hand and surface disinfectants. These offerings are prominently marketed under brands like Bobini, Apart, Biophen, Mole, Sofin, Izo, and Izozid. The company officially adopted its current name, Dr. Miele Cosmed Group S.A., in March 2024, having previously operated as Global Cosmed S.A.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Dr. Miele Cosmed Group S.A. (DMG.WA)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Dr. Miele Cosmed Group S.A., founded in 1990 and headquartered in Radom, Poland, is actively involved in the global production and distribution of a diverse array of chemical and cosmetic products. Their extensive portfolio includes personal hygiene items such as shower gels, liquid soaps, and sanitizing gels and sprays, alongside a dedicated range for children encompassing washing and care cosmetics, wet wipes, and laundry detergents. The company also manufactures household cleaning essentials, offering toilet cleaners, toilet blocks, drain openers (in granule and gel form), washing liquids, fabric softening concentrates, and specific agents for kitchen and bathroom cleaning, as well as hand and surface disinfectants. These offerings are prominently marketed under brands like Bobini, Apart, Biophen, Mole, Sofin, Izo, and Izozid. The company officially adopted its current name, Dr. Miele Cosmed Group S.A., in March 2024, having previously operated as Global Cosmed S.A.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free